Henry Ν. C. Wong
X.Q. Deng Presidential Chair Professor
Also affiliated: Lyon 1 Université (2025); Toyobo (Japan) (1987); Library and Archives Canada (2005); Centre National de la Recherche Scientifique (2004–2025); Hong Kong Baptist University (2005–2010); Hong Kong Polytechnic University (1984); Bristol-Myers Squibb (Germany) (1983–2016); Jinan University (2015); Namangan State University (1988); Chinese University of Hong Kong (1973–2025); American University (1998); University of Basel (1975–1991); University of Toronto (1993–2011); Chinese Academy of Sciences (2001–2025); Hong Kong University of Science and Technology (1999); UCL Australia (1976); Spencer Foundation (1983); Shatin Hospital (2014–2019); Hospital for Sick Children (2011–2013); Toronto General Hospital (1993); University Grants Committee (2007–2012); Southern University of Science and Technology (2022–2023); ProQuest (United States) (2005); Victoria University of Wellington (1972); SAIC-GM (China) (2014); Bristol-Myers Squibb (United States) (1983–2016); Institute of Molecular Functional Materials (2011–2017); École Supérieure des Télécommunications (2005); City University of Hong Kong, Shenzhen Research Institute (2014); Bristol-Myers Squibb (Canada) (1985); Shanghai Advanced Research Institute (2003–2016); Shanghai Institute of Organic Chemistry (1984–2025); Chinese University of Hong Kong, Shenzhen (2013–2025); Delaware Division of Libraries (2014); State Key Laboratory of Synthetic Chemistry (2002–2023); École Nationale Supérieure d'Architecture de Bretagne (2005); National Research Council Canada (1975); Chemical Synthesis Lab (2014–2025); École Nationale des Travaux Publics de l'État (2004–2025); European Space Research and Technology Centre (2004); University College London (1975–1981); Carleton University (2005); Henan Normal University (2019); Zhejiang University (1999); Delaware Technical Community College (2014); University of Hong Kong (2004–2020)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Henry N. C. Wong, a Presidential Chair Professor at the University of Arkansas for Medical Sciences, directs a research group focusing on chemical synthesis and its applications in medicine and materials science. His work encompasses the development of novel catalytic methods for the enantioselective synthesis of complex organic molecules. This includes palladium-catalyzed cycloaddition reactions to form dihydrofurans and iridium-catalyzed alkynylation and kinetic resolution of allylic alcohols.
Wong's research also extends to the investigation of therapeutic agents, particularly in the area of cancer treatment. Publications detail the efficacy and safety of photodynamic therapy for cutaneous T-cell lymphoma and the use of improved formulations of monoclonal antibodies for autoimmune diseases of the skin. His group explores the molecular underpinnings of diseases, examining how cellular interactions and gene expression influence conditions like cutaneous T-cell lymphoma.
With a substantial publication record (617 publications) and a high citation count (9,262 citations), Wong is recognized as a highly cited researcher. His collaborations within the University of Arkansas for Medical Sciences include work with Sophia Ly, Delice Kayishunge, Sara C. Shalin, and Dmitry A. Nedosekin, with whom he has co-authored multiple publications.
Metrics
- h-index: 48
- Publications: 622
- Citations: 9,286
Selected Publications
-
Association Between Dietary Folate and Prostate Cancer Aggressiveness Among African Americans and European Americans (2026)
-
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome (2025)
-
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (2024)
-
Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature (2023)
-
HyBryte™ use in early-stage cutaneous T-cell lymphoma (2023)
-
The effect of comorbid autoimmune gastrointestinal diseases on time to resolution of pyoderma gangrenosum: A retrospective review (2023)
-
266 Analysis of novel sezary syndrome genes in mycosis fungoides reveals genes common across stages and those associated with advanced stages (2023)
-
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin (2023)
-
A case of typical mycosis fungoides in an HIV-positive patient (2022)
-
34350 Treatment with rituximab for refractory adult dermatomyositis complicated with calcinosis cutis (2022)
-
Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities (2022)
-
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) (2022)
-
112 Gene expression changes in sezary syndrome patients following mogamulizumab treatment refines biomarker and immune profile (2022)
Federal Grants 1
Epigenetic Regulation of Differentially Expressed Genes in Cutaneous T Cell Lymphoma
Collaboration Network
Top Collaborators
- Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
- Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities
- 34350 Treatment with rituximab for refractory adult dermatomyositis complicated with calcinosis cutis
- 324 Epidemiologic trends of mycosis fungoides and sezary syndrome in Arkansas reveals increasing incidence and disparities
- A case of typical mycosis fungoides in an HIV-positive patient
Showing 5 of 6 shared publications
- Epidemiologic Trends of Cutaneous T-Cell Lymphoma in Arkansas Reveals Demographic Disparities
- Progression of pyoderma gangrenosum with angioinvasive fungus
- 324 Epidemiologic trends of mycosis fungoides and sezary syndrome in Arkansas reveals increasing incidence and disparities
- A case of typical mycosis fungoides in an HIV-positive patient
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
- Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
- Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
- The effect of comorbid autoimmune gastrointestinal diseases on time to resolution of pyoderma gangrenosum: A retrospective review
- Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
- Milia en plaque manifesting as a post-herpetic isotopic response
- Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma
- Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
- Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
- Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma
- Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
- Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
- Progression of pyoderma gangrenosum with angioinvasive fungus
- A case of typical mycosis fungoides in an HIV-positive patient
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
- 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
- Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
- HyBryte™ use in early-stage cutaneous T-cell lymphoma
Similar Researchers
Based on overlapping research topics